Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Early treatment helps stop hair loss in women of color.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The document concludes that more research is needed to fully understand the causes of PCOS.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

People with seborrheic dermatitis often have lower vitamin D levels.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Hyaluronic acid and polycaprolactone improve skin regeneration, with polycaprolactone having a stronger effect on healing and tissue repair.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Iron supplements combined with Quilib lotion effectively treat hair loss in people with iron deficiency anemia.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Stem-cell therapy shows promise for skin conditions but needs more research.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Hair loss treatments work better with lifestyle changes.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Alopecia patients have less GPER-1, which might affect hair loss.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Women with PCOS have distinct retinal changes compared to healthy women.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.